| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |